CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $1.56B, above the global median of $1.15B
- FinancialsAltman Z-Score -0.33: distress zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.56BUSDvs all stocks (USD)
Revenue (TTM)
2.28BUSDvs all stocks (USD)
Profit Margin
-49.91%vs Medical Devices peers
Beta
1.50xvs all stocks
52-Week Change
2.93%vs all stocks
Market Capitalization
1.56BUSDvs all stocks (USD)
Enterprise Value
3.00BUSDvs all stocks (USD)
Forward P/E
6.64xvs Medical Devices peers
Price to Sales (TTM)
0.6839xvs Medical Devices peers
Price to Book (MRQ)
1.05xvs Medical Devices peers
Enterprise to Revenue
1.31xvs Medical Devices peers
Enterprise to EBITDA
8.05xvs Medical Devices peers
Gross Margin
62.04%vs Medical Devices peers
Profit Margin
-49.91%vs Medical Devices peers
Operating Margin
3.64%vs Medical Devices peers
Return on Assets (TTM)
1.09%vs Medical Devices peers
Return on Equity (TTM)
-55.35%vs Medical Devices peers
Revenue (TTM)
2.28BUSDvs all stocks (USD)
Revenue per Share (TTM)
39.83USDUpdated Jul 18, 2026Quarterly Revenue Growth
5.40%vs Medical Devices peers
Gross Profit (TTM)
1.39BUSDvs all stocks (USD)
EBITDA (TTM)
333.87MUSDvs all stocks (USD)
Net Income (TTM)
-1.14BUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
5.43%vs Medical Devices peers
Operating Cash Flow (TTM)
242.84MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
206.90MUSDvs all stocks (USD)
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
2.26MUSDFY2025 · Dec 31, 2025Revenue
2.25BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
902.79MUSDFY2025 · Dec 31, 2025Gross Profit
1.35BUSDFY2025 · Dec 31, 2025Operating Income
-18.87MUSDvs all stocks (USD)
Pre-tax Income
-1.16BUSDFY2025 · Dec 31, 2025Income Tax Expense
22.29MUSDFY2025 · Dec 31, 2025Net Income
-1.18BUSDFY2025 · Dec 31, 2025EBIT
-1.12BUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
275.14MUSDFY2025 · Dec 31, 2025Research & Development
120.33MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
1.07BUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
34.82MUSDFY2025 · Dec 31, 2025EPS (Basic)
-20.75USDFY2025 · Dec 31, 2025EPS (Diluted)
-20.75USDFY2025 · Dec 31, 2025Basic Shares Outstanding
57.07MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
57.07MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-1.18BUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
-820.00KUSDFY2025 · Dec 31, 2025Operating Cash Flow
-835.70MUSDFY2025 · Dec 31, 2025Free Cash Flow
-1.03BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
36.39MUSDFY2025 · Dec 31, 2025Income Tax Paid
18.38MUSDFY2025 · Dec 31, 2025Interest Paid
27.45MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-1.18BUSDFY2025 · Dec 31, 2025Depreciation & Amortization
294.38MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-2.23MUSDFY2025 · Dec 31, 2025Stock-based Compensation
32.92MUSDFY2025 · Dec 31, 2025Other Non-cash Items
7.38MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-10.75MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-1.14MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
27.35MUSDFY2025 · Dec 31, 2025Capital Expenditures
-197.38MUSDFY2025 · Dec 31, 2025Net Acquisitions
16.40MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-180.97MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
544.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-580.92MUSDFY2025 · Dec 31, 2025Other Financing Charges
-16.79MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-52.40MUSDFY2025 · Dec 31, 2025Shares Outstanding
57.54MSharesUpdated Jul 18, 2026Float Shares
56.59MSharesUpdated Jul 18, 2026Shares Short
9.50MSharesUpdated Jul 18, 2026Short Ratio
7.89daysvs all stocks
Short % of Shares Outstanding
19.67%vs all stocks
% Held by Insiders
1.63%vs all stocks
% Held by Institutions
121.73%vs all stocks
Total Cash (MRQ)
33.13MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.5760USDUpdated Jul 18, 2026Total Debt (MRQ)
1.41BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.9534xvs Medical Devices peers
Current Ratio (MRQ)
2.04xvs Medical Devices peers
Book Value per Share (MRQ)
25.66USDUpdated Jul 18, 2026Total Assets
3.83BUSDvs all stocks (USD)
Total Current Assets
1.21BUSDFY2025 · Dec 31, 2025Total Liabilities
2.34BUSDFY2025 · Dec 31, 2025Total Non-current Assets
2.63BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
1.74BUSDFY2025 · Dec 31, 2025Total Current Liabilities
598.47MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
36.39MUSDFY2025 · Dec 31, 2025Accounts Receivable
442.79MUSDFY2025 · Dec 31, 2025Inventory
584.38MUSDFY2025 · Dec 31, 2025Accounts Payable
187.53MUSDFY2025 · Dec 31, 2025Short-term Debt
59.74MUSDFY2025 · Dec 31, 2025Deferred Revenue
6.50MUSDFY2025 · Dec 31, 2025Other Current Liabilities
51.48MUSDFY2025 · Dec 31, 2025Long-term Debt
1.32BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
424.57MUSDFY2025 · Dec 31, 2025Common Stock (Book)
57.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-1.47BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
1.49BUSDvs all stocks (USD)
52-Week Low
19.14USDUpdated Jul 18, 202652-Week High
34.28USDUpdated Jul 18, 202652-Week Change
2.93%vs all stocks
Beta
1.50xvs all stocks
50-Day MA
23.66USDUpdated Jul 18, 2026200-Day MA
25.64USDUpdated Jul 18, 2026Avg 10-Day Volume
1.18MSharesUpdated Jul 18, 2026Avg 30-Day Volume
1.20MSharesUpdated Jul 18, 2026Diluted EPS (TTM)
-19.89USDUpdated Jul 18, 2026Other Income / Expense
-1.11BUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.62Profit Margin: -0.50
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 2.04Altman Z-Score: -0.33
Financial Health
Altman Z-Score -0.33: distress zoneCritical
Altman Z-Score: -0.33
High earnings qualityNotable
Earnings Quality Score: 1.92
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $1.56B, above the global median of $1.15BNotable
Market cap (USD): 1,558,219,663Global Median: 1,146,734,693.424
Revenue is $2.28B, above the global median of $520.53MNotable
Revenue (USD): 2,278,365,952Global Median: 520,528,949.311
Levered free cash flow is $206.9M, above the global median of $16.24MNotable
Levered free cash flow (USD): 206,902,368Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Green Thumb Industries Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
Maze Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hualan Biological Engineering Inc.
Tier 1ProductionApproval-Gated PipelineRule
Recursion Pharmaceuticals, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Arrivent Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Forte Biosciences, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Harbin Gloria Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Classys Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sihuan Pharmaceutical Holdings Group Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Yantai Dongcheng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule